These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 9427261

  • 1. Paclitaxel and carboplatin in head and neck cancer.
    Dunphy F, Boyd J, Dunleavy T.
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-25-S19-27. PubMed ID: 9427261
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A phase I report of paclitaxel dose escalation combined with a fixed dose of carboplatin in the treatment of head and neck carcinoma.
    Dunphy FR, Boyd JH, Kim HJ, Dunphy CH, Harrison BR, Dunleavy TL, Rodriguez JJ, McDonough EM, Minster JR, Hilton JG.
    Cancer; 1997 May 15; 79(10):2016-23. PubMed ID: 9149030
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Concurrent paclitaxel, carboplatin, and radiotherapy in advanced head and neck cancers: a phase II study--preliminary results.
    Chougule P, Wanebo H, Akerley W, McRae R, Nigri P, Leone L, Safran H, Ready N, Koness RJ, Radie-Keane K, Cole B.
    Semin Oncol; 1997 Dec 15; 24(6 Suppl 19):S19-57-S19-61. PubMed ID: 9427268
    [Abstract] [Full Text] [Related]

  • 6. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
    Hitt R, Hornedo J, Colomer R, Mendiola C, Brandariz A, Sevilla E, Alvarez-Vicent J, Cortés-Funes H.
    Semin Oncol; 1995 Dec 15; 22(6 Suppl 15):50-4. PubMed ID: 8643971
    [Abstract] [Full Text] [Related]

  • 7. Combination paclitaxel (1-hour) and carboplatin (AUC 7.5) in advanced non-small cell lung cancer: a phase II study by the Fox Chase Cancer Center Network.
    Langer CJ, Millenson M, O'Dwyer P, Kosierowski R, Alexander R, Litwin S, McAleer CA, Bonjo CA, Ozols R.
    Semin Oncol; 1996 Dec 15; 23(6 Suppl 16):35-41. PubMed ID: 9007119
    [Abstract] [Full Text] [Related]

  • 8. Paclitaxel (1-hour) and carboplatin (area under the concentration-time curve 7.5) in advanced non-small cell lung cancer: a phase II study of the Fox Chase Cancer Center and its network.
    Langer CJ, Millenson M, Rosvold E, Litwin S, McAleer CA, Bonjo CA, Ozols R.
    Semin Oncol; 1997 Aug 15; 24(4 Suppl 12):S12-81-S12-88. PubMed ID: 9331128
    [Abstract] [Full Text] [Related]

  • 9. Paclitaxel, carboplatin, and long-term continuous 5-fluorouracil infusion in the treatment of upper aerodigestive malignancies: preliminary results of phase II trial.
    Hainsworth JD, Meluch AA, Greco FA.
    Semin Oncol; 1997 Dec 15; 24(6 Suppl 19):S19-38-S19-42. PubMed ID: 9427264
    [Abstract] [Full Text] [Related]

  • 10. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.
    Shin DM, Glisson BS, Khuri FR, Lippman SM, Ginsberg L, Diaz E, Papadimitrakopoulou V, Feng L, Francisco M, Garden A, Kies MS, Myers J, Clayman G, Hong WK.
    Cancer; 2002 Jul 15; 95(2):322-30. PubMed ID: 12124833
    [Abstract] [Full Text] [Related]

  • 11. Preoperative paclitaxel, carboplatin, and radiation therapy in advanced head and neck cancer (stage III and IV).
    Wanebo HJ, Chougule P, Ready N, Koness RJ, Akerley W, McRae R, Nigri P, Leone L, Webber B, Safran H.
    Semin Radiat Oncol; 1999 Apr 15; 9(2 Suppl 1):77-84. PubMed ID: 10210544
    [Abstract] [Full Text] [Related]

  • 12. Induction paclitaxel and carboplatin for patients with head and neck carcinoma. Analysis of 62 patients treated between 1994 an 1999.
    Dunphy FR, Dunleavy TL, Harrison BR, Trinkaus KM, Kim HJ, Stack BC, Needles B, Boyd JH.
    Cancer; 2001 Mar 01; 91(5):940-8. PubMed ID: 11251945
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Paclitaxel combined with carboplatin in the first-line treatment of advanced ovarian cancer: a phase I trial.
    Meerpohl HG, du Bois A, Luck HJ, Kühnle H, Möbus V, Kreienberg R, Bauknecht T, Köchli O, Bochtler H, Diergarten K.
    Semin Oncol; 1997 Feb 01; 24(1 Suppl 2):S2-17-S2-22. PubMed ID: 9045330
    [Abstract] [Full Text] [Related]

  • 16. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma.
    Edelman MJ, Meyers FJ, Houston J, Lauder I.
    Semin Oncol; 1997 Oct 01; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226
    [Abstract] [Full Text] [Related]

  • 17. Paclitaxel (1-hour infusion) plus carboplatin in the treatment of advanced non-small cell lung cancer: results of a multicenter phase II trial.
    Greco FA, Hainsworth JD.
    Semin Oncol; 1997 Aug 01; 24(4 Suppl 12):S12-14-S12-17. PubMed ID: 9331113
    [Abstract] [Full Text] [Related]

  • 18. Carboplatin plus paclitaxel in the first-line treatment of advanced ovarian cancer: preliminary results of a phase I study.
    Lhommé C, Kerbrat P, Lejeune C, Guastalla JP, Fumoleau P, Goupil A, Héron JF, Cassin MA, Pruvot I, Soares JA, Chazard M.
    Semin Oncol; 1996 Oct 01; 23(5 Suppl 12):48-54. PubMed ID: 8941410
    [Abstract] [Full Text] [Related]

  • 19. Paclitaxel combined with carboplatin in the first-line treatment of advanced ovarian cancer.
    Meerpohl HG, du Bois A, Kühnle H, Lück HJ, Kreienberg R, Möbus V, Bauknecht T, Köchli O, Bochtler H, Diergarten K.
    Semin Oncol; 1995 Dec 01; 22(6 Suppl 15):7-12. PubMed ID: 8643973
    [Abstract] [Full Text] [Related]

  • 20. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy.
    Weiner LM, Colarusso P, Goldberg M, Dresler C, Coia LR.
    Semin Oncol; 1997 Dec 01; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.